![]() |
|
|
Faculty of Medical and Health Sciences, The Liggins Institute, University of Auckland, Auckland, New Zealand
Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors that are involved in lipid metabolism, differentiation, proliferation, cell death, and inflammation. Three subtypes have been identified: PPAR-
, -
, and -
. We have previously shown presence of PPAR-
mRNA in the amnion, choriodecidua, and placenta, and its level of expression was unchanged with labor. To evaluate whether PPAR-
and -
subtypes are present in intrauterine tissues, placentae were obtained from women at term after spontaneous vaginal delivery (TSL; n = 15) and elective caesarean section before labor (TNL; n = 15). Northern blot analyses were used to evaluate the mRNA for PPARs. Activities of PPARs were assessed using JEG3 choriocarcinoma cells transfected with a PPAR-response element reporter construct (pTK-PPREx3-luc) and treated with PPAR ligands. The PPAR-
-specific ligand rosiglitazone induced PPAR response element (PPRE)-mediated activity in a concentration-dependent manner, whereas the PPAR-
-specific irreversible inhibitor GW9662 fully inhibited this induction. However, GW9662 only partially inhibited 15-deoxy-
12,14-prostaglandin J2 (15d-PGJ2)-induced luciferase activity, suggesting that 15d-PGJ2 may also activate either of the other isoforms. PPAR-
and -
are expressed in the amnion, choriodecidua, and placental villous tissues. In the amnion, although for PPAR-
no significant difference in expression was observed with labor, PPAR-
expression increased significantly (p < 0.001). In the choriodecidua, expression of PPAR-
declined with labor (p < 0.01), whereas, as in the amnion, PPAR-
expression increased (p < 0.05). In the placenta, both PPAR-
and -
expression increased with labor (p < 0.005). The changes observed with labor suggest that regulation of PPAR expression and function may have roles to the mechanisms that maintain pregnancy or initiate labor.
Address correspondence to: Elicia Berry, The Liggins Institute, University of Auckland, Private Bag 92019, Auckland, New Zealand. E-mail: ebe.berry{at}auckland.ac.nz
This article has been cited by other articles:
![]() |
D. E. Keil, T. Mehlmann, L. Butterworth, and M. M. Peden-Adams Gestational Exposure to Perfluorooctane Sulfonate Suppresses Immune Function in B6C3F1 Mice Toxicol. Sci., May 1, 2008; 103(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Takacs and B. D. Abbott Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ({alpha}, {beta}/{delta}, {gamma}) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate Toxicol. Sci., January 1, 2007; 95(1): 108 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Froment, F Gizard, D Defever, B Staels, J Dupont, and P Monget Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J. Endocrinol., May 1, 2006; 189(2): 199 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. A. Helliwell, J. A. Keelan, K. W. Marvin, L. Adams, M. C. Chang, A. Anand, T. A. Sato, S. O'Carroll, T. Chaiworapongsa, R. J. Romero, et al. Gestational Age-Dependent Up-Regulation of Prostaglandin D Synthase (PGDS) and Production of PGDS-Derived Antiinflammatory Prostaglandins in Human Placenta J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 597 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. E. Berry, J. A. Keelan, R. J. A. Helliwell, R. S. Gilmour, and M. D. Mitchell Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B Mol. Pharmacol., July 1, 2005; 68(1): 169 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M Lindstrom and P. R Bennett 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Interleukin-1{beta}-Induced Nuclear Factor-{kappa}B in Human Amnion and Myometrial Cells: Mechanisms and Implications J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3534 - 3543. [Abstract] [Full Text] [PDF] |
||||